| P2093 | author name string | H Frank | |
| | J B Sørensen | |
| | T Palshof | |
| P2860 | cites work | Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma | Q24243222 |
| | Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study | Q33329809 |
| | Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II study | Q33348171 |
| | Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma | Q34214330 |
| | A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group | Q34295028 |
| | Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis | Q34979814 |
| | Emerging insights into the biology and therapy of malignant mesothelioma | Q35061755 |
| | Pleural mesothelioma: little evidence, still time to do trials | Q35903121 |
| | Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma | Q36643866 |
| | The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline | Q36780619 |
| | Assessment of tumor response in malignant pleural mesothelioma | Q36926206 |
| | Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience | Q41688263 |
| | Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. | Q44267257 |
| | Phase II Study of Pemetrexed With and Without Folic Acid and Vitamin B12 as Front-Line Therapy in Malignant Pleural Mesothelioma | Q44405249 |
| | Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma | Q44708516 |
| | A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesothelioma | Q46590810 |
| | Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Inst | Q46726893 |
| | Short-term treatment-related symptoms and quality of life: results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an EORTC Lung-Cancer Group and National Can | Q46919069 |
| | Inadequacy of the new Response Evaluation Criteria in Solid Tumors (RECIST) in patients with malignant pleural mesothelioma: report of four cases | Q47293797 |
| | Modified RECIST criteria for assessment of response in malignant pleural mesothelioma | Q61628213 |
| | Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: Outcomes of an expanded access program | Q61889857 |
| | Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients | Q72256266 |
| | Phase II study of vinorelbine in patients with malignant pleural mesothelioma | Q73250833 |
| | Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study | Q74784116 |
| | The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent | Q78846264 |
| | Chemotherapy for malignant pleural mesothelioma: past results and recent developments | Q80355524 |
| | The palliative benefits of MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in patients with malignant mesothelioma | Q80470953 |
| | Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma | Q82892136 |
| | Malignant pleural mesothelioma | Q83143116 |
| | Current concepts in chemotherapy for malignant pleural mesothelioma | Q83364333 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cisplatin | Q412415 |
| | chemotherapy | Q974135 |
| P304 | page(s) | 44-50 | |
| P577 | publication date | 2008-06-10 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma | |
| P478 | volume | 99 | |